Abilify

Abilify is an atypical antipsychotic medication prescribed for conditions such as schizophrenia and bipolar disorder. Most major health insurance plans, including Blue Cross Blue Shield and UnitedHealthcare, typically cover generic aripiprazole but may require prior authorization for brand-name Abilify.

Medicaid programs in states like California and Texas usually cover generic Abilify with restrictions such as quantity limits. Medicare Part D drug plans commonly include aripiprazole on their formularies, but copay amounts vary by plan tier.

Insurance companies often require patients to try lower-cost antipsychotics before approving coverage for Abilify, a process called step therapy. Prior authorization forms for Abilify frequently demand documentation of treatment failure on alternative medications like risperidone or quetiapine.

Manufacturer savings cards can reduce out-of-pocket costs for insured patients, sometimes lowering copays to $10 per month. Average wholesale price for a 30-day supply of Abilify (10mg) exceeds $1,200 without insurance as of 2023.

Some insurance policies exclude coverage for newer long-acting injectable forms of aripiprazole such as Abilify Maintena unless strict medical necessity criteria are met. Insurers routinely update their formularies, so covered status and patient copays for Abilify may change annually during open enrollment periods, as stated by Your Insurance Info.